Скачать или смотреть Screening for Colon Cancer at home with the Second Generation FIT fecal immunochemical test kit.

Second Generation FIT® is the revolutionary test to aid in the detection of Colorectal Cancer that is fast, accurate, and easy to use. Now you can test for the same advanced colon cancer biomarker that hospitals, labs, and physicians offices do in the privacy of your own home, with no diet or medicine restrictions. Unscrew the tube, pictured above, to expose the wand. Collect a small sample of fecal matter from your tissue paper, and insert the wand back into the tube. Shake the tube, then apply three drops onto the cassette and read your results. The entire test takes five minutes or less and the fecal immunochemical test is considered a preferred screening method for Colorectal Cancer Detection by the U.S. Preventative Services Task Force, the National Colorectal Cancer Roundtable, the American College of Gastroenterology, the American Cancer Society, and the CDC (Center for Disease Control). Second Generation FIT® is amazingly accurate, detecting globlin levels at 50 ng/mL (50 billionths of a gram). The American College of Gastroenterology recommends a FIT test once per year, and recognizes the Fecal Immunochemical Test as the number one alternative to colonoscopy. In fact, in a recent study of over 26,000 patients, FIT caught more colon cancers than colonoscopy did. Recent studies show the fecal immunochemical test is as accurate as colonoscopy when preformed annually.
Second Generation FIT® is the number one selling colon cancer screening test in North America for a reason. Take the test when you want, in the privacy of your own home, with instant results.
Second Generation FIT® is the go-to colon cancer screening test for hospitals, health fairs and non-profits who are screening large numbers of people.
Second Generation FIT® is also the test of choice for large clinical trials. When the drug Casperome® was in clinical trials to manage patients with ulcerative colitis in remission, doctors depended on Second Generation FIT® to provide the vital information regarding remission status they needed using the fecal immunochemical test.